4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-17-001399
PRESIDENT, CHIEF STRATEGY OFF. bought 10,000 shares at $3.15 ($31,500)
From the SEC's structured data for this filing
Trades in this filing
Fried Robert N · PRESIDENT, CHIEF STRATEGY OFF.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-15 | Purchase : show line 1 in the form | +10,000 | $3.15 | $31,500 | 583,241 | D |
| Open-market purchases · 10,000 sh · avg $3.15 · $31,500 | ||||||
Loading xslF345X03/form4-08162017_010858.xml…